News articles about Varian Medical Systems (NYSE:VAR) have trended positive recently, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.27 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 46.8402252503228 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the news headlines that may have effected Accern Sentiment’s analysis:
- Varian Medical Systems Inc.: Varian Announces First Quarter Fiscal Year 2018 Earnings Release Date (twst.com)
- Learn details of the External Beam Radiotherapy Market Size 2022 Varian … (medgadget.com)
- Global Radiotherapy Market Top Companies Are Varian Medical Systems, Inc … (medgadget.com)
- Growth of Portable X-Ray and CT Scan Device Market in Future, According to Research Nester. (einpresswire.com)
A number of analysts recently weighed in on VAR shares. Robert W. Baird restated a “hold” rating and issued a $99.00 price target on shares of Varian Medical Systems in a research note on Monday, August 28th. Royal Bank of Canada reiterated a “hold” rating and set a $100.00 target price on shares of Varian Medical Systems in a research report on Friday, September 1st. BTIG Research downgraded Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Finally, Citigroup boosted their target price on Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research report on Monday, October 30th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. Varian Medical Systems currently has a consensus rating of “Hold” and a consensus price target of $98.39.
Varian Medical Systems (VAR) traded up $0.27 during trading on Tuesday, reaching $111.45. The company had a trading volume of 454,001 shares, compared to its average volume of 858,802. The firm has a market capitalization of $10,259.26, a price-to-earnings ratio of 29.70, a P/E/G ratio of 3.29 and a beta of 0.67. Varian Medical Systems has a 52-week low of $76.94 and a 52-week high of $113.58.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.19 by ($0.10). The firm had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The business’s revenue was down 1.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 earnings per share. research analysts forecast that Varian Medical Systems will post 4.26 earnings per share for the current fiscal year.
In other news, EVP Kolleen T. Kennedy sold 2,021 shares of the stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $107.36, for a total value of $216,974.56. Following the completion of the sale, the executive vice president now owns 27,595 shares in the company, valued at $2,962,599.20. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director R Andrew Eckert sold 5,651 shares of the stock in a transaction dated Friday, October 6th. The shares were sold at an average price of $102.39, for a total value of $578,605.89. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,683 shares of company stock valued at $2,645,965. Insiders own 0.91% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Varian Medical Systems (VAR) Earns Daily Media Sentiment Score of 0.27” was posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.truebluetribune.com/2017/12/12/varian-medical-systems-var-earns-daily-media-sentiment-score-of-0-27.html.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.